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Abstract
The staphylococcal accessory gene regulatory (agr) operon is a well-characterised global regulatory element that is
important in the control of virulence gene expression for Staphylococcus aureus, a major human pathogen. Hence, accurate
and sensitive measurement of Agr activity is central in understanding the virulence potential of Staphylococcus aureus,
especially in the context of Agr dysfunction, which has been linked with persistent bacteraemia and reduced susceptibility
to glycopeptide antibiotics. Agr function is typically measured using a synergistic haemolysis CAMP assay, which is believe
to report on the level of expression of one of the translated products of the agr locus, delta toxin. In this study we develop a
vesicle lysis test (VLT) that is specific to small amphipathic peptides, most notably delta and Phenol Soluble Modulin (PSM)
toxins. To determine the accuracy of this VLT method in assaying Agr activity, we compared it to the CAMP assay using 89
clinical Staphylococcus aureus isolates. Of the 89 isolates, 16 were designated as having dysfunctional Agr systems by the
CAMP assay, whereas only three were designated as such by VLT. Molecular analysis demonstrated that of these 16 isolates,
the 13 designated as having a functional Agr system by VLT transcribed rnaIII and secreted delta toxin, demonstrating they
have a functional Agr system despite the results of the CAMP assay. The agr locus of all 16 isolates was sequenced, and only
the 3 designated as having a dysfunctional Agr system contained mutations, explaining their Agr dysfunction. Given the
potentially important link between Agr dysfunction and clinical outcome, we have developed an assay that determines this
more accurately than the conventional CAMP assay.
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Introduction
Staphylococcus aureus is a Gram-positive bacterial pathogen that
plays a major role in human disease. It is an opportunistic
pathogen which inhabits the moist squamous epithelium of the
anterior nares, permanently colonising approximately 20% of the
population and found intermittently in another 50% [1]. This
organism can cause a wide array of diseases from superficial skin
lesions to more serious life-threatening illnesses, being the leading
bacterial agent in infective endocarditis [2,3,4]. S. aureus expresses
many different secreted and surface-associated virulence factors
which are utilised during all stages of infection [5].
The staphylococcal accessory gene regulator (agr) quorum
sensing system is central in the ability of this organism to promote
infection, through coordinated, temporal expression of specific
virulence genes, in which cell surface adhesins are synthesised and
expressed before secreted toxins and enzymes [6,7]. Previous
studies have shown that a functional Agr system is important in
several infection models including a murine arthritic [8] and
subcutaneous abscesses model [9] as well as rabbit endocarditis
[10]. The shift in gene expression is tightly correlated with
population density and sensing of a diffusible signal molecule by
the Agr two-component system. The Agr system is comprised of a
3 kb locus with two divergent transcripts, RNAII and RNAIII,
driven by independent promoters P2 and P3. The P2 operon
encodes the two-component system, AgrA and C, which responds
to the autoinducing peptide AgrD, after processing and secretion
through AgrB, and after reaching a critical peptide threshold
concentration, allowing a phosphorylated form of AgrA to drive
expression from the two agr promoters. The P3 dependent
regulatory RNA, RNAIII, is the effector molecule of this regulon
and is involved in the up - and down - regulation of specific genes
as well as encoding the delta toxin. This complex alteration in
expression of virulence genes occurs in conjunction with many
global regulators namely the DNA-binding Sar family of proteins
[11,12], the alternative sigma factor [13] and other two-
component system such as SaeRS [14] and ArlRS [15].
Recently, there has been much research into Agr dysfunction,
particularly on the outcomes of infection with isolates containing
mutations in the agr locus, which can range in prevalence from 10–
20% of S. aureus clinical isolates [16,17]. These mutations can
occur during infection in the patient [18] and have been
implicated in an increased mortality in patients suffering from
bacteremia [17,19]. The increased survival of Agr defective strains
observed in persistent bacteremia has been hypothesised to involve
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a defect in autolysis [20], owing to the fact that several murein-
hydrolase genes are regulated by agr [21]. This phenotype has
been implicated in the increased survival of Agr dysfunctional
strains in the presence of platelet derived antimicrobial peptides
and reduced sensitivity to gylcopeptide antibiotics, namely
vancomycin [20].
The conventional method of assessing Agr function is to
demonstrate delta toxin’s haemolytic activity using a blood agar
plate assay in combination with a beta haemolysin positive strain,
usually RN4220 [22]. Additionally, Agr activity can be monitored
through other methods such as Northern blotting or quantitative
reverse transcriptase-PCR (qRT-qPCR) with probes or primers
directed at RNA III, and recently Whole-Cell Matrix Assisted
Laser Desorption Ionization-Time-of-Flight (MALDI-TOF) mass
spectrometry [23]. However, Northern blotting and qRT-PCR are
time consuming and expensive, but considerably more sensitive
than the CAMP assay, and a MALDI-TOF mass spectrometer
costs several hundred thousand dollars to purchase, although
running costs are low [24]. Here we describe the development of a
new methodology that determines Agr activity in a fast, high-
throughput, sensitive and quantitative manner. This method is
based on the interaction of delta and Phenol Soluble Modulin
(PSM) toxins, both used as surrogate markers for RNAIII and
RNAII activity respectively, with lipid vesicles containing encap-
sulated self-quenched fluorescent dye. Recent work in this group
has focused on the development of a sensor for bacterial infection
in burns [25,26] which is dependent on toxin-lipid interaction.
One fundamental element in the transition from inactive toxin
monomers into fully functional membrane-damaging agents is the
lipid and protein composition of the target membranes, particu-
larly important in artificial membranes. We have formulated a
lipid vesicle system that is responsive to specific toxins, the small a-
helical, amphiphatic delta and PSM toxins. When compared to
the conventional CAMP assay this method proved more accurate,
identifying all the isolates in a collection of 89 clinical S. aureus
isolates that had mutations in the agr locus, unlike the CAMP assay
that had 13 false positives. As such, if Agr dysfunction becomes
more widely accepted as being a critical determinant in the clinical
outcome of infection, the accuracy of the VLT assay suggests that
it should be used ahead of the plate based CAMP assay.
Results and Discussion
Vesicle Breakdown Correlates with Early Stationary Phase
Growth and is agr Dependent
Methicillin-susceptible S. aureus strain MSSA476 is a commu-
nity-acquired invasive isolate for which a genome sequence is
available [27]. To determine if and at what stage of growth
MSSA476 lysed the lipid vesicles, a range of concentrations of
bacteria were used to inoculate broth containing the vesicles.
Toxin production in bacteria is strictly growth-phase regulated
and density dependent, with bacteria relying on the secretion of
auto-inducing peptides to communicate and regulate genes [28].
Figure 1(a) (top) shows the vesicle breakdown/fluorescence
response, observed for the three start inoculums to be growth
phase dependent; being triggered in the early stationary phase in
each case. Due to the requirement of bacteria reaching stationary
phase, the role of quorum sensing and the agr operon was
investigated. Supernatants derived from wild type RN6390B and
isogenic agr knockout RN6911 were used (fig. 1b) to measure the
fluorescence response of vesicles to secreted toxins. It was observed
that the wild type but not the isogenic agr mutant strain caused
lysis, demonstrating the importance of a functional agr system for
vesicle lysis.
Identification of the Toxins Lysing the Lipid Vesicles
S. aureus expresses a number of toxins that are regulated by the
Agr system. These toxins differ in their mode of action and host
receptor specificity, which results in the lysis of different cell types
by different toxins. To determine which staphylococcal toxins
were causing vesicle lysis, a number of isogenic mutants were
assayed (Table 1). The S. aureus 8325-4 laboratory strain and the
isogenic hla (alpha toxin) and hlb (beta toxin) mutants were used to
assess the role of these two toxins (fig. 2a). It has been known that
alpha toxin damages protein free liposomes and that phosphati-
dylcholine head groups play a vital role in initial association
[29,30]. 1, 2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) is a
major component of the vesicles under study (53%) and for this
reason we explored the role of alpha toxin mediated breakdown of
vesicles. Figure 2(a) clearly shows that both the alpha and beta
toxin knockout strains caused vesicle lysis at virtually identical
levels as the wild type strain, showing that neither toxin were
critical in vesicle lysis or caused maximum fluorescence release in
these experiments. Alpha toxin mediated lysis requires the
clustering of phosphatidylcholine head groups within membrane
microdomains enriched in cholesterol and sphingomyelin while
the absence of either membrane proteins or the absence of
sufficient clustering lead to the inhibition of monomer heptamer-
ization [30] and therefore no lytic event. Furthermore, in the lipid
vesicles used here, TCDA was used to stabilize the membrane via
cross linking of the acyl chains of DPPC, and this is believed to
prevent such head group clustering, rendering the monomers
incapable of binding and penetrating the membrane. The beta -
toxin is an enzyme which acts as on sphingomyelin [31] and
consistent with its activity, no difference in vesicle lysis was
observed using the beta - toxin mutant.
The Panton-Valentine leukocidin (PVL), gamma-haemolysin
and the leukocidin family (notably LukAB and lukDE) belong to
the bicomponent pore-forming family of toxins. In similar fashion
to the alpha-toxin, these leukocidins require specific receptor(s) for
lysing biological membranes [32,33,34,35] but may still lyse
artificial membranes [36]. Therefore we wanted to investigate
whether any measurable difference could be seen between
supernatants derived from USA400 MW2 wild type and isogenic
PVL mutant and strain Newman and the respective LukAB,
LukDE and hlgACB mutants. Due to the high toxin production of
these strains and sensitivity of vesicles, supernatants were separated
in 5 - fold dilutions. No measurable difference was observed
between wild type and mutant strains with our vesicle type. It has
been shown previously that gamma-haemolysin can permeate
liposomes composed of PC head groups [36], however our results
are consistent with two pieces of evidence which also proves that
this toxin does not have the capacity to bind and permeabilize this
vesicle type. Firstly, the lipid composition is crucial for this toxins’
activity with short (less than 13 carbon atoms) acyl chains being
vital for pore-forming ability [37]. The vesicles in question are
composed of longer (16 carbon atoms) causing cholesterol to
integrate below the DPPC head groups permitting packaging not
conducive to monomer binding [37]. Secondly, this toxin, as with
alpha-toxin, is susceptible to heat-inactivation at 65uC for 30
minutes [38] and since heat inactivated supernatants were still able
to lyse vesicles with the same ability as un - treated supernatant
(fig. 2e) over a defined period (20 min exposure), illustrates that the
toxin was not involved in lysis.
S. aureus also produces a number of enzymes, some with lipolytic
activity such as (phospho) lipases. These enzymes are heat-sensitive
and to investigate whether these enzymes had an effect on vesicle
lysis, we first demonstrated the inactivation of these enzymes in the
bacterial supernatant of a selection of clinical isolates following
Vesicle Assay for         AGR
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heat treatment using using a lipase plate assay (fig. 2d). These heat-
treated supernatants retained their vesicle lytic activities, demon-
strating that these enzymes were not the main lytic agent of this
system.
This vesicle type was constructed with the aim of being
susceptible to delta and PSM toxins and therefore we have
eliminated the possible involvement of other known staphylococcal
toxins. It has been previously shown that delta toxin can retain its
alpha helical structure in phosphatidylcholine bilayers and causes
membrane perturbation and lysis in a concentration dependent
manner [39]. This was illustrated for delta toxin and also for the
PSM alpha toxin 1, 2 and 3 whereas PSMa4 and PSMb1 and 2
had reduced lytic activity (fig. 3a), which may be due to the
structural properties of these peptides and investigations into this is
ongoing in our lab. We chose to look closer at delta and PSM3a
toxins due to their relevance in immune cell damage, however,
PSM alpha 1 and 2 also showed vesicle lysis with similar
efficiencies to PSM3a (data not shown). Above a concentration
of 2.5 mM and 1.5 mM for delta and PSM3a respectively, vesicle
lysis occurs rapidly, whereas below this magnitude, lysis is reduced
by approximately 20–30 % of maximum fluorescence (fig. 3b and
d). The concentration of delta and PSM3a required to lyse 50 %
of vesicles (V50) is 1.5 mM and 0.25 mM respectively. By
comparing this to the LD50 for biologically relevant T - cells
which are derived from an immortalized T - cell line [40] the
sensitivity of the vesicles to these peptides is illustrated. A 50 - fold
(delta) and 16 - fold (PSM3a) increase in toxin concentration is
required to cause lysis of 50 % of T - cells (fig. 3(c)(e). It has been
shown previously that PSM concentrations of greater than 30 mg/
ml were required to cause lysis of human neutrophils [41]. When
using PSM3a as an example, this roughly equates to a
concentration of approximately 11.5 mM, whereas for the
immortalized T-cells, a concentration of approximately 5 mM
results in lysis of 50% of T-cells, highlighting the differences in
susceptibility of different cell types to PSMs. These differences in
susceptibility may be due to the origin of cells, as those
experiments using PMN were freshly isolated from human
volunteers whereas the T-cells are harvested from in vitro growth.
Comparison of Two Phenotypic Assays in Measuring agr
Activity
Having developed an assay that responds to the activity of delta
toxin, we wanted to establish how this vesicle lysis test (VLT) assay
compared to the conventional delta haemolysin plate CAMP assay
for determining Agr function. 89 clinical S. aureus strains were
tested including 51 hospital acquired and 38 community acquired
isolates from diverse genetic backgrounds. Of the 89 strains
assayed using the CAMP assay 17.98% (16 of 89) exhibited no
synergy between delta and beta haemolysins on the blood agar
plates (fig. 4a) and as such were designated as having a
dysfunctional Agr system. Using the VLT only 3.3 % (3 of 89)
Figure 1. Vesicle lysis occurs during early stationary phase growth. A) Different starting inocula (104, 105, and 106 cfu/ml) of MSSA 476 were
used to assess vesicle lysis during bacterial growth. By monitoring optical density and fluorescence it was evident that vesicle lysis occurs at early
stationary phase. Bacteria were grown for 18 h with lipid vesicles B) Supernatants of wild-type (RN6390B) and the isogenic agr knockout (RN6911)
strains, highlights the central role that the agr operon plays in vesicle lysis. 0.01% Triton X-100 and HEPES buffer were used as positive and negative
controls respectively Supernatants were incubated with lipid vesicles for 30 min and fluorescence measured every 2 min.
doi:10.1371/journal.pone.0087270.g001
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had reduced lytic activity, as measured by fluorescence compara-
ble to the negative control (Hepes buffer) and were classified as agr
dysfunctional (fig. 4b). Using LAC and its isogenic hld mutant it
was shown that the synergistic effect of haemolysis could also be
observed in the absence of translated delta toxin, an observation
that Cheung et al have previously shown. These authors have
identified S. aureus PSMs involvement in the synergistic haemolysis
with beta toxin when grown on blood agar [42].
Validation of the Sensitivity of the VLT by Measuring
RNAIII Expression
To determine which of the two assays (CAMP or VLT) were
assaying Agr activity accurately we measured the level of
expression on RNAIII in all 16 isolates defined as Agr
dysfunctional by the CAMP assay by qRT-PCR (fig. 5). Only
the three isolates defined as Agr dysfunctional by both the CAMP
and the VLT assays were impaired in the expression of RNAIII
(MSSA71, MRSA378 and MSSA707). We also qualitatively
assayed the secretion of small amphiphatic peptides (i.e. delta
toxin and the PSMs) by these isolates (fig. 6). Although variability
existed in the secretion of these peptides across all 16 isolates, only
the three designated as being Agr dysfunctional by VLT secreted
had no detectable amount of peptide. One of the limiting factors of
using this extraction technique is that it may not be sensitive
enough to detect all the PSMs, especially if there are low - level
expressed. Therefore, we extracted the sample and analysed it by
LC/MSMS and identified it as delta toxin. None of the other
PSMs were detected in this band.
Agr sequencing
The agr locus of all 16 isolates designated as having dysfunc-
tional Agr systesm by the CAMP assay were sequenced. Only the
three designated as such by both VLT and CAMP were found to
have mutations in this locus (fig. 7). These three strains were from
different clonal complexes and therefore we used respective
reference strains to align the sequences. All three isolates had
1 bp deletions occurring within a run of adenine (MSSA71 and
MRSA378) or thymine (MSSA707) residues. In MSSA71 this lead
to a premature stop codon in AgrA truncating the protein at
position 49; in MRSA378 this caused frameshift mutation and the
Table 1. Bacterial strains, peptide sequences and primers used in this study.
Strain/peptide/primer Description Reference
S. aureus
RN6390B NCTC8325 cured of three prophages [57]
RN6911 RN6390B Dagr::tetM [50]
8325-4 Lab strain NCTC8325 cured of three prophages [58]
DU1090 8325-4 Dhla::Emr [59]
DU5719 b-haemolysin –ve Phage 42E lysogen of 8325-4 [52]
LAC (USA300) Community acquired MRSA strain [60]
LAC Dhld LAC hld deletion mutant; hld start codon changed from ATG to ATT [61]
MW2 (USA400) Community acquired MRSA strain [60]
MW2 Dpvl MW2 DlukF/S-PV::spcm [60]
MSSA 476 Community-acquired invasive MSSA strain [54]
RN4220 Restriction negative derivative of 8325-4 [62]
Newman MSSA lab strain [63]
NewmanDlukAB Constructed using pKOR-1 plasmid [63]
NewmanDlukDE Constructed using pKOR-1 plasmid [63]
NewmanDhlg NewmanDhlg::tetM [64]
Purified toxins
Delta toxin fMAQDIISTIGDLVKWIIDTVNKFTKK
PSMa1 fMGIIAGIIKVIKSLIEQFTGK
PSMa2 fMGIIAGIIKFIKGLIEKFTGK
PSMa3 fMEFVAKLFKFFKDLLGKFLGNN
PSMa4 fMAIVGTIIKIIKAIIDIFAK
PSMb1 fMEGLFNAIKDTVTAAINNDGAKLGTSIVSIVENGVGLLGKLFGF
PSMb2 fMTGLAEAIANTVQAAQQHDSVKLGTSIVDIVANGVGLLGKLFGF
Primers
gyrB Forward CCAGGTAAATTAGCCGATTGC
gyrB Reverse AAATCGCCTGCGTTCTAGAG
RNA III Forward GAAGGAGTGATTTCAATGGCACAAG
RNA III Reverse GAAAGTAATTAATTATTCATCTTATTTTTTAGTGAATTTG
Abbreviations: agr, accessory gene regulator; hla, gene for a-toxin; pvl, gene for Panton-Valentine Leucocidin; hld, delta hemolysin; luk, leukocidin; hlg, gamma
haemolysin; PSM, phenol soluble modulin; gyrB, DNA gyrase B.
doi:10.1371/journal.pone.0087270.t001
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addition of 22 amino acids at the C-terminal end of AgrA protein;
and in MSSA707 this lead to the truncation of the AgrC protein at
position 176. With regards to the other non-haemolytic strains
(MSSA41, MRSA69, MSSA101, MRSA119, MSSA144,
MSSA215, MRSA252, MSSA304, MRSA312, MRSA354,
MRSA393, MSSA406, MRSA448) and haemolytic strain
(MRSA325), these had the same agr sequence apart from
MRSA69 and MRSA325 which were identical and of a different
agr group ( agr-1 as opposed to agr-3). Therefore differences in agr
sequence did not account for the differences in haemolytic activity
within these two strains.
Conclusions
Lipid vesicles have also been extensively used to study toxin-
membrane interactions [30,33,36,37,43]. Toxin destruction of
biological membranes generally requires specific receptors, a key
element in toxin specificity to certain cells. Synthetic lipid vesicles
allow different receptor components, such as cholesterol, glyco-
lipids and phospholipids to be incorporated at varying concentra-
tions allowing the possibility of being able to tune the vesicles
response to different lytic toxins [44]. In this study we formulate a
lipid vesicle that is lysed by a specific group of small, amphipathic,
alpha-helical peptides, regulated by the staphylococcal Agr system
but unresponsive to other known Agr regulated toxins. This vesicle
contains some features consistent with certain eukaryotic mem-
branes, most notably comprising a percentage of cholesterol
reflecting that of erythrocyte membranes (20–25% [45]) and
featuring two very common membrane phosphoglycerides,
phosphatidylcholine and phosphatidylethanolamine. However,
our vesicles lack any glycolipids or sphingomyelin, which can be
in high proportion in certain cell types [45]. The similarity in
composition of our vesicle system to some eukaryotic membranes
is reflected in the similar concentrations of purified toxins required
to lyse erythrocytes and our vesicles. In general, erythrocytes lysis
occurs after incubation with 10 mg/ml (approximately 3.85 mM) of
individual PSMs [42], whereas our vesicles require in the range of
1.5–2.5 mM depending on the peptide toxins, both systems
requiring incubation at 37uC for 30 min. If we compare this to
the results of PSM interaction with POPC vesicles used by Duong
et al we see a stark difference in the concentration of PSMs used
Figure 2. Deducing toxins/enzyme involvement in vesicle lysis. A) Deletion of a-or b-toxin had no measurable effect on vesicle lysis. B) 5-fold
dilutions of MW2 and MW2Dpvlmutant and C) Newman, NewmanDlukAB, NewmanDlukDE and NewmanDhlgACB illustrate the lack of involvement of
the Panton-Valentine leukocidin and leukocidin AB, leukocidin DE and the gamma-haemolysin in lysis of vesicles. D) Phospholipase plate assay
showing phospholipase activity as an orange halo around un-treated supernatant filled wells in contrast to no activity with heat-inactivated
supernatants. E) 95uC Heat-treatment of supernatants retains vesicle lysis ability, suggesting no involvement of either phospholipases or gamma
haemolysin in vesicle lysis (see text for details). Lipid vesicles were incubated with bacterial supernatants for 30 min.
doi:10.1371/journal.pone.0087270.g002
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and incubation time required to cause lysis [46]. For POPC
vesicles, PSM concentrations were in the range of 0.5 – 1.0 mM
and incubated for 200 s to reach maximum lysis. Moreover, the
order in which the PSM peptides caused lysis of POPC vesicles is
quite different to the order for normal cellular lysis and order of
our vesicles, with the PSM b1 and b2 peptides and PSM4a
causing the highest degree of lysis in POPC vesicles whereas these
peptides have the lowest lytic capabilities under physiological
conditions [47] and our vesicles (fig. 3a). The increase in time and
toxin concentration required to lyse our vesicle type in comparison
to pure POPC is based a number of factors, but largely dependent
on the cholesterol composition in our vesicle type. Cholesterol
plays a major role in membrane fluidity and the transition
temperature of lipids which has an overall impact on the
mechanical rigidity of the lipid membrane [48] from which we
hypothesise will have a profound effect on toxin - mediate lysis of
vesicles and understanding this process is work which is ongoing in
our lab. The POPC vesicles are unsaturated and are therefore
packed less tightly which may influence toxin binding and
disruption of the membrane; unsaturation also lowers the
transition temperature and is more prone to oxidation [49] again
affecting membrane integrity.
Agr dysfunction is an increasingly important issue due to its
relevance with regard to persistent bacteraemia and decreased
antibiotic glycopeptide susceptibility such as to vancomycin
[19,20]. Loss of Agr activity is also implicated in increased biofilm
formation and attachment to inert surfaces, which is important as
the majority of bloodstream hospital acquired infections are
catheter associated [50,51]. However, the majority of these studies
looking at correlations between Agr dysfunction and clinical
outcomes use the CAMP assay.
We suggest that the use of the CAMP assay for determining Agr
activity may not be sufficiently sensitive in determining Agr
function. Using our VLT assay we correctly identified the only 3
isolates from a collection of 89 that had mutations in the Agr locus
(summarised in Table 2). A possible confounder of the VLT
method is their sensitivity to the other PSM toxins. It has been
shown previously that psm genes can be regulated in an RNAIII-
independent manner, with AgrA being important in this up-
regulation [52]. However, this also affects the outcome of the
CAMP assay, as we show in Fig. 4a. We must also keep in mind
that the vast majority of strains that produce detectable levels of
PSMs are the highly toxic community acquired type IV SCCmec
strains, which produce considerably higher concentrations of delta
toxin than PSM [47]. No examples of Agr dysfunction have been
Figure 3. Effect of purified toxins on lipid vesicles and T – cells. A) Vesicle rupture as a result of incubation with 10 mM synthetic PSM and
delta peptides for 30 min B) Lysis of vesicles and C) T-cells subjected to selected concentrations of purified delta toxin. D) Lysis of vesicles and E) T-
cells subjected to selected concentrations of purified PSM3a toxin. The vesicle system is highly sensitive to both toxins at low concentrations, while
PSM3a is more potent at lysing both vesicles and T-cells than delta toxin. T-cells were incubated for 15 min at 37uC with purified toxins.
doi:10.1371/journal.pone.0087270.g003
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reported amongst this group, indeed Agr function is believed to be
critical to their emergence and virulence [53], suggesting that
neither the VLT or the CAMP assay will be of use clinically for
these types of infection.
The question that this study also touches on is how much Agr
activity is required to determine a strain to be functional, semi-
functional or have complete inactivity? We have suggested that
those strains which were VLT negative and non-haemolytic were
the only true Agr inactive isolates, acquiring mutations leading to
truncation of essential proteins. This VLT is a sensitive, rapid
assay which is quick and easy to perform and amenable to 96-well
plate high-throughput analysis and may help us in redefining the
Agr activity of clinical isolates.
Materials and Methods
Bacterial Strains and Culture Conditions
Frequently used bacterial strains are listed (Table 1). Wildtype S.
aureus strains isolated from patients with invasive disease (51
hospital acquired and 38 community acquired) within Oxford-
shire, United Kingdom, between 1997 and 1998 are described
previously [54]. All strains were routinely stored at280uC in 15 %
glycerol/broth stocks until required. S. aureus strains were streaked
onto Tryptic Soy agar and single colonies transferred to 5 mL
Tryptic Soy broth and propagated in a shaking incubator for 18 h
at 37uC. Bacterial growth was measured at OD600 nm at 37uC and
shaking at 300 rpm in Costar 96-well round – bottomed plates in
tandem with fluorescence using a dual absorbance/ fluorescence
script. To identify specific roles of toxins in vesicle lysis, bacterial
supernatants were heated to 95uC for one hour.
Figure 4. Differences in agr activity observed using two methods. A) Delta haemolysin plate assay of agr positive (RN6390B) and negative
(RN6911) strains, 17 S. aureus clinical isolates, 16 which are designated as agr – negative, one agr positive isolate and agr – positive LAC and its
corresponding isogenic hld mutant strain, signifying the effects of delta toxin and PSM on the haemolysin plate assay. B) Normalized fluorescence
measurements of 89 clinical S. aureus strains using the vesicle–supernatant method, highlighting the three strains causing no vesicle lysis.
doi:10.1371/journal.pone.0087270.g004
Vesicle Assay for        AGR        Determination
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Vesicle Formulation
Vesicle suspensions were prepared by mixing lipid and fatty acid
components in chloroform: 25 mol % of 10, 12-Tricosadiynoic
acid, 53 mol % 1, 2-dipalmitoyl-sn-glycero-3-phosphocholine,
2 mol % 1, 2-dipalmitoyl-sn-glycero-3-phosphoethanolamine and
20 mol % of cholesterol. The dried lipid was rehydrated using
10 mL of 50 mM 5(6)-carboxyfluorescein (CF) in HEPES buffer
solution, vortexed and heated in a hot water bath at 75uC for 10
minutes. Three freeze/thaw cycles were carried out by initially
immersing the lipid-containing vial in liquid nitrogen and then
heating the vial back to room temperature to homogenize the
solution [55]. A turbid solution was an indication of vesicle
formation. Vesicles were then extruded 3 times at 50uC using a
Liposofast vesicle extruder through 2 6 0.1 mm polycarbonate
filters under nitrogen pressure. The initial opaque vesicle solution
becomes translucent after extrusion. The vesicle solution was then
purified using illustra Nap-25 columns (GE Healthcare) to remove
unencapsulated CF dye. The columns were washed with 15 mL of
HEPES buffer to remove the 0.15% Kathon CG/ICP biocide.
2 mL of vesicle solution was added to each column and allowed to
load. 1 mL of HEPES buffer was then added and left to drain.
After this a further 2 mL of HEPES buffer was added and the
resultant pure vesicle solution was collected and stored at 4uC
overnight. These 10, 12-tricosadiynoic acid vesicles were then
cross-linked using a CL1000 Ultraviolet crosslinker on setting 1 for
6 seconds. All chemicals were purchased from Sigma-Aldrich and
lipids from Avanti Polar lipids. As a quick method to illustrate CF
encapsulated vesicles, 0.01% v/v Triton X-100 and HEPES was
used as a positive and negative control respectively.
Vesicle Toxicity Assay
The vesicle toxicity assay was designed de novo were experimen-
tal conditions were optimised before use. Fluorescence intensity
was measured at excitation and emission wavelengths of 485–
520 nm respectively on a FLUOROstar fluorimeter (BMG
Labtech). Depending upon the experiment, two different assays
were employed, one utilising whole bacterial cells and the other
using bacterial culture supernatant. In the first method, bacterial
culture was normalised to a specific colony forming unit/ml (cfu/
ml) achieved through correlation with optical density. An
overnight culture (18 h) washed twice in PBS and diluted to an
OD of 0.1 which represented 106 CFU/ml. This was serially
diluted to 105 and 104 CFU/ml in TSB. 200 ml of bacterial
culture was added to 50 ml of vesicle solution in triplicate. The
fluorescence of each sample was then measured at 5 min intervals
for 18 h. Positive and negative controls were pure vesicles with
0.01% Triton X-100 and HEPES respectively. For the superna-
tant assay, bacteria were grown for 18 h, supernatant was
harvested by centrifugation at 14000 rpm for 10 min and filter
sterilized through a 0.22 mm filter. 50 ml of vesicle solution was
incubated with 50 ml of bacterial supernatant or differing
concentrations of purified delta toxin or PSMs (Biomatik; 99%
purity) and measured for 30 min with the above parameters.
Normalised fluorescence was achieved using the equation (Ft–F0)/
(Fm/F0) where Ft is the average fluorescence value at a specific
time point, F0 is the minimum and Fm is the maximum
fluorescence value in that particular experiment.
Figure 5. Measurement of rnaIII transcription. Real – time qPCR results of 19 strains consisting of the positive and negative control RN6390B
and RN6911 respectively, the 3 negative vesicle lysis test strains (MSSA 71, MRSA 378 and MSSA 707), 13 non-haemolytic strains and the haemolytic
strain MRSA 325. Illustrates rnaIII transcription in those strains designated agr positive by vesicle method and no transcription is evident in those 3
strains which show no lysis of vesicles.
doi:10.1371/journal.pone.0087270.g005
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Lipase Plate Assay
Lipase plate assay was designed as described previously with
some minor modifications [56]. Olive oil (1 %) and rhodamine B
(0.001 %) were used as substrate and added to the agar medium
after sterilization and cooling to 60uC. 3-mm-diameter holes were
punched into the agar and 50 ml of cell-free supernatant harvested
from 18 h stationary phase bacterial cultures were added and left
Figure 6. SDS-PAGE of concentrated agr regulated peptides. Concentrated and extracted proteins from several S. aureus strains, showing the
presence of protein bands, indicating a mix of delta and PSM peptides. Purified delta peptide and RN6390B used as a positive control and RN6911 as
a negative control. Figure shows the absence of bands in those strains which cause no lysis of vesicles.
doi:10.1371/journal.pone.0087270.g006
Figure 7. Mutations in VLT negative isolates. Isolates MSSA71, MRSA378 and MSSA707 all contained 1 bp deletions (bold) which led to
truncation or alteration of essential agr proteins. The reference strain is given (top) along with the strain in which the mutation was shown to occur in
(Bottom). Nucleotide positions are given at the 5’ end of the sequence.
doi:10.1371/journal.pone.0087270.g007
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to incubate for 18 h at 37uC. Plates were irradiated with a UV
light and images captured on a Nikon camera.
CAMP Assay
The conventional method to determine or measure agr
functionality is via delta – haemolysin production. This was
determined by streaking the beta – haemolysin positive S. aureus
RN4220 strain on washed sheep blood agar (SBA) plates. The test
strains are streaked perpendicular to this strain and any enhanced
zone of haemolysis where the delta lysin [22] or PSM
peptides[Cheung] overlaps with the beta – haemolysin zone was
scored positive for delta haemolysin production and thus agr
activity [22].
T-cell Toxicity Assay
To analyse the difference in sensitivity between a biological
membrane and vesicles to purified toxins, an adaptation of the T-
cell toxicity assay was used as described previously [40]. All
experiments were done in duplicate with three biological repeats.
RNA Isolation
Cultures of S. aureus grown overnight were diluted 1:1000 into
fresh TSB and grown at 37uC for 8 h (late exponential phase)
at which time samples were collected for RNA isolation.
Cultures were treated with two volumes of RNAprotect
(Qiagen) incubated at room temperature for 10 min, centrifuged
and resuspended in Tris 0.05 M (pH 7.5) and the pellet further
treated with 300 ml of EDTA 0.5 M/ lysostaphin (5 mg ml21)
and incubated for 1 h. RNA was then isolated using the Qiagen
RNeasy Midi Kit according to the manufacturer’s instructions
with the addition of Turbo DNase (Invitrogen) after the
purification step. The RNA was quantified using the Qubit
RNA assay kit (Invitrogen) and the absence of DNA verified by
PCR using standard primers.
Reverse Transcription and qRT-PCR
Reverse transcription of messenger RNA to complementary
DNA (cDNA) was generated using the SuperScript II Reverse
Transcriptase (Invitrogen) according to manufacturer’s instruc-
tions using random hexamers (Qiagen). Primers used for gyrase B
(gyrB) and RNA III are listed in Table 1. Standard curves were
generated for both primer sets on serial dilutions of cDNA to
determine primer efficiency. The reverse-transcriptase PCR (RT-
PCR) was performed as follows: 5 ml cDNA, 7.5 ml SYBR reagent
(BioRad), 0.5 ml forward and reverse primer and RNase-free water
(Sigma) to a total volume of 15 ml. The cDNA was subjected to
real-time PCR using the Applied Biosystems Step-One Real Time
PCR detection system (Applied Biosystems). Cycling conditions
were 95uC for 10 min followed by 40 cycles of 95uC for 15 s and
60uC for 1 min and a dissociation step 95uC for 15 s and 60uC for
1 min. Cycle threshold values were determined for 3 biological
repeats in duplicate. For each reaction, the ratio of RNA III and
gyrB transcript number was calculated as follows: 2(Ct gyrB – Ct
RNAIII).
Peptide Extraction and SDS-PAGE
Overnight cultures of S. aureus were diluted 1:1000 into 50 ml
TSB and grown at 37uC for 18 h, after which cultures were
centrifuged and 30 ml of cell – free supernatants were mixed
with 10 ml 1-butanol. Extraction was performed by shaking
mixed solutions for 3 h at 37uC. Samples were then centrifuged
for 3 min for complete separation and the upper organic phase
was collected, aliquoted into 1 ml tubes and concentrated using
a vacuum oven overnight at 40uC. Dried samples were dissolved
in 200 ml of 8 M urea. Aliquots were mixed with 26Laemmlli
sample buffer and heated at 95uC for 5 min before being
subjected to SDS-PAGE (10% acrylamide). This was performed
in triplicate and a representative coomassie stained gel can be
Table 2. Key characteristics of CAMP and VLT assayed strains.
Strain CC Agr type CAMP VLT (N Fluor)" RNAIII Expression* Agr locus/ mutation
MSSA41 30 III Negative 0.716.04 5.761.4 Identical to MRSA252
MRSA69 30 I Negative 0.956.09 8.962.1 Identical to MRSA325
MSSA71 1 III Negative 0.056.01 0.026.01 -1bp(nt147) AgrA
MSSA101 30 III Negative 0.986.07 1163.1 Identical to MRSA252
MRSA119 30 III Negative 0.856.02 10.963.7 Identical to MRSA252
MSSA144 30 III Negative 0.996.07 11.264.6 Identical to MRSA252
MSSA215 30 III Negative 0.806.09 9.761.4 Identical to MRSA252
MRSA252 30 III Negative 0.736.11 9.564.2 MRSA252
MSSA304 30 III Negative 0.916.03 9.463.1 Identical to MRSA252
MRSA312 30 III Negative 0.656.05 5.961.7 Identical to MRSA252
MRSA325 30 I Positive 0.926.05 8.861.4 Identical to MRSA69
MRSA354 30 III Negative 0.736.11 4.861.6 Identical to MRSA252
MRSA378 30 III Negative 0.036.01 0.0560.03 -1bp(nt705) AgrA
MRSA393 30 III Negative 0.646.16 4.6461.2 Identical to MRSA252
MSSA406 30 III Negative 0.926.07 10.662.9 Identical to MRSA252
MRSA448 30 III Negative 0.956.14 7.461.9 Identical to MRSA252
MSSA707 16 II Negative 0.056.02 0.836.3 -1bp(nt487) AgrC
Abbreviations: CC; Clonal complex, CAMP; synergistic haemolysis plate assay, VLT; vesicle lysis test.
"Values shown in normalised fluorescence units.
*qRT-PCR after 8 hours.
doi:10.1371/journal.pone.0087270.t002
Vesicle Assay for        AGR        Determination
PLOS ONE | www.plosone.org 10 January 2014 | Volume 9 | Issue 1 | e87270
seen in fig. 6. Bands were excised and sent for LCMSMS at the
Central Proteomics Facility at the University of Oxford.
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